Home/Hedge Fund Intelligence/NewAmsterdam Pharma Co N.V.
Nasdaq: NAMSStockForm 13F30 Jun 2026

Hedge funds that hold NewAmsterdam Pharma Co N.V. Ordinary Shares Nasdaq: NAMS

Ordinary Shares · CUSIP N62509109 · who reports it, how much, and how much it matters to them

30 of the 720 hedge fund managers we track reported shares of NewAmsterdam Pharma Co N.V. (Nasdaq: NAMS) on Form 13F for 30 June 2026. Between them they reported USD 858m. The largest position belongs to Ra Capital Management, at USD 324m. The manager with the most riding on it is Artia Global Partners, where it is 3.2% of the reported book.

Managers reporting it30of 720 we track
Value they reportUSD 858mshares only, 30 Jun 2026
Funds they run341with a file on PPLI.com
Largest positionUSD 324mRa Capital Management
Typical weight0.1%median share of a manager's book
Heaviest weight3.2%Artia Global Partners

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

30 managers, USD 858m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports NewAmsterdam Pharma Co N.V., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Ra Capital Management1 fund on PPLI.comUSD 324m2.8%
2Viking Global Investors4 funds on PPLI.comUSD 142m0.4%
3Maverick Capital20 funds on PPLI.comUSD 111m1.0%
4Polar Capital LLP26 funds on PPLI.comUSD 58m0.1%
5Castle Hook Partners1 fund on PPLI.comUSD 46m0.2%
6Citadel Advisors32 funds on PPLI.comUSD 22m0.0%
7Rock Springs Capital Management2 funds on PPLI.comUSD 20m1.0%
8Adage Capital Management1 fund on PPLI.comUSD 19m0.0%
9Artia Global Partners1 fund on PPLI.comUSD 17m3.2%
10Millennium Management6 funds on PPLI.comUSD 17m0.0%
11Cormorant Asset Management1 fund on PPLI.comUSD 17m0.9%
12Slate Path Capital3 funds on PPLI.comUSD 11m0.1%
13Exoduspoint Capital Management7 funds on PPLI.comUSD 10m0.1%
14Eversept Partners3 funds on PPLI.comUSD 9.3m0.5%
15Arrowmark Colorado Holdings24 funds on PPLI.comUSD 7.2m0.3%
16POINT72 Asset Management17 funds on PPLI.comUSD 5.7m0.0%
17D. E. Shaw & Co.15 funds on PPLI.comUSD 4.1m0.0%
18Walleye Capital8 funds on PPLI.comUSD 3.8m0.0%
19Squarepoint Ops7 funds on PPLI.comUSD 3.1m0.0%
20Schonfeld Strategic Advisors30 funds on PPLI.comUSD 3m0.0%
21Tudor Investment Corporation10 funds on PPLI.comUSD 2.7m0.0%
22Palo Alto Investors6 funds on PPLI.comUSD 1.5m0.2%
23Boothbay Fund Management2 funds on PPLI.comUSD 1.2m0.0%
24HighVista Strategies27 funds on PPLI.comUSD 708,0000.2%
25Engineers Gate Manager1 fund on PPLI.comUSD 662,0000.0%
26Two Sigma Investments35 funds on PPLI.comUSD 407,0000.0%
27Brevan Howard Capital Management39 funds on PPLI.comUSD 324,0000.0%
28Persistent Asset Partners10 funds on PPLI.comUSD 247,0000.1%
29The Quarry1 fund on PPLI.comUSD 154,0000.0%
30Bayforest Capital1 fund on PPLI.comUSD 43,2780.0%
Next: where it matters most
Where it matters most

For Artia Global Partners it is 3.2% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Artia Global PartnersUSD 17m3.2%
2Ra Capital ManagementUSD 324m2.8%
3Maverick CapitalUSD 111m1.0%
4Rock Springs Capital ManagementUSD 20m1.0%
5Cormorant Asset ManagementUSD 17m0.9%
6Eversept PartnersUSD 9.3m0.5%
7Viking Global InvestorsUSD 142m0.4%
8Arrowmark Colorado HoldingsUSD 7.2m0.3%
9Castle Hook PartnersUSD 46m0.2%
10Palo Alto InvestorsUSD 1.5m0.2%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds NewAmsterdam Pharma Co N.V.

What is the ticker symbol of NewAmsterdam Pharma Co N.V.?

NewAmsterdam Pharma Co N.V. trades under the symbol NAMS on the Nasdaq. Its CUSIP, the code used on Form 13F, is N62509109.

Which hedge funds own NewAmsterdam Pharma Co N.V. (Nasdaq: NAMS)?

30 of the 720 hedge fund managers PPLI.com tracks reported NewAmsterdam Pharma Co N.V. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 324m), Viking Global Investors (USD 142m), Maverick Capital (USD 111m), Polar Capital LLP (USD 58m) and Castle Hook Partners (USD 46m).

How many hedge funds hold NewAmsterdam Pharma Co N.V.?

30 managers in our coverage reported it, and between them they run 341 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on NewAmsterdam Pharma Co N.V.?

Artia Global Partners, where the position was 3.2% of the reported 13F book at 30 June 2026.

Does this show who is short NewAmsterdam Pharma Co N.V.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with NewAmsterdam Pharma Co N.V. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.